We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
DuPont de Nemours Inc | NYSE:DD | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
-0.08 | -0.10% | 77.67 | 78.38 | 77.14 | 78.38 | 2,391,433 | 01:00:00 |
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE TO
(Rule 14d-100)
TENDER OFFER STATEMENT UNDER SECTION 14(D)(1) OR 13(E)(1)
OF THE SECURITIES EXCHANGE ACT OF 1934
AMENDMENT NO. 3
DuPont de Nemours, Inc.
(Name of Subject Company (Issuer))
DuPont de Nemours, Inc.
(Name of Filing Person (Offeror))
Common Stock, $0.01 par value
(Title of Class of Securities)
26614N102
(CUSIP Number of Class of Securities)
Erik T. Hoover
Senior Vice President & General Counsel
974 Centre Road, Building 730
Wilmington, Delaware 19805
(302) 774-3034
(Name, address, and telephone number of person authorized to receive notices and communications on behalf of filing persons)
Copies to:
Brandon Van Dyke | Christopher E. Austin | |
Skadden, Arps, Slate, Meagher & Flom LLP | Benet J. OReilly | |
One Manhattan West | Kyle A. Harris | |
New York, NY 10001 | Cleary Gottlieb Steen & | |
(212) 735-3000 | Hamilton LLP | |
One Liberty Plaza | ||
New York, NY 10006 | ||
(212) 225-2000 |
CALCULATION OF FILING FEE
Transaction Valuation | Amount of Filing Fee | |
$15,705,955,575(1) |
$1,713,519.75(2) | |
|
||
(1) |
Estimated solely for calculating the filing fee, based on the average of the high and low prices (as reported on the New York Stock Exchange on December 29, 2020) of shares of common stock, par value $0.125 per share, of International Flavors & Fragrances Inc. (IFF) into which shares of common stock, par value $0.01 per share, of Nutrition & Biosciences, Inc. being offered in exchange for shares of common stock, par value $0.01 per share, of DuPont De Nemours, Inc., will be converted, and paid in connection with IFFs Registration Statement on Form S-4, which was initially filed on May 7, 2020 (Registration No. 333-238072) (the IFF Form S-4), calculated as set forth therein, relating to the transactions described in this Schedule TO. |
(2) |
The amount of the filing fee has been calculated in accordance with Rule 0-11 under the Securities Exchange Act of 1934, as amended, in connection with the IFF Form S-4, as set forth therein. |
☒ |
Check the box if any part of the fee is offset as provided by Rule 0-11(a)(2) and identify the filing with which the offsetting fee was previously paid. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. |
Amount Previously Paid: $2,352,247.57 |
Filing Party: International Flavors & Fragrances Inc. | |
Form or Registration No.: Form S-4 (Registration No. 333-238072) |
Date Filed: May 7, 2020 |
☐ |
Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer. |
Check the appropriate boxes below to designate any transaction to which the statement relates:
☐ |
third party tender offer subject to Rule 14d-1. |
☒ |
issuer tender offer subject to Rule 13e-4. |
☐ |
going private transaction subject to Rule 13e-3. |
☐ |
amendment to Schedule 13D under Rule 13d-2. |
Check the following box if the filing is a final amendment reporting the results of the tender offer: ☐
This Amendment No. 3 amends and supplements the Issuer Tender Offer Statement on Schedule TO filed by DuPont de Nemours, Inc. (DuPont) with the Securities and Exchange Commission (the SEC) on December 31, 2020, as amended by Amendment No. 1 and Amendment No. 2 to the Issuer Tender Offer Statement, filed with the SEC on January 11, 2021 and January 25, 2021, respectively (as so amended, the Schedule TO).
This Schedule TO relates to the offer by DuPont to exchange all shares of common stock, par value $0.01 per share (N&B common stock), of Nutrition & Biosciences, Inc. (N&B) for shares of common stock, par value $0.01 per share (DuPont common stock), of DuPont, upon the terms and subject to the conditions set forth in the Prospectus dated December 31, 2020 (the Prospectus), the Letter of Transmittal and the Exchange and Transmittal Information Booklet, copies of which are attached hereto as Exhibits (a)(1)(i), (a)(1)(ii) and (a)(1)(iii), respectively (which, together with any amendments or supplements thereto, collectively constitute the Exchange Offer). Following the consummation of the Exchange Offer, the remaining shares, if any, of N&B common stock will be distributed in a clean-up spin-off on a pro rata basis to DuPont stockholders as of the applicable record date (Clean-Up Spin-Off) as described in the Prospectus. Immediately following the Exchange Offer and the Clean-Up Spin-Off, Neptune Merger Sub I Inc., a Delaware corporation and wholly owned subsidiary of IFF (Merger Sub), will be merged with and into N&B, whereby the separate corporate existence of Merger Sub will cease and N&B will continue as the surviving corporation and a wholly owned subsidiary of IFF (the Merger). In the Merger, each outstanding share of N&B common stock (except for shares of N&B common stock held by N&B as treasury stock or by DuPont, which will be automatically cancelled) will be automatically converted into the right to receive shares of common stock, par value $0.125 per share, of IFF (IFF common stock), upon the terms and subject to the conditions set forth in the Prospectus.
In connection with the Exchange Offer, N&B has filed with the Securities and Exchange Commission (the SEC), under the Securities Act of 1933, as amended (the Securities Act), a registration statement on Form S-4 and Form S-1 (Registration No. 333-238089) (as amended, the Registration Statement) to register the shares of N&B common stock offered in exchange for shares of DuPont common stock tendered in the Exchange Offer and to be distributed in the Clean Up Spin-Off to the extent that the Exchange Offer is not fully subscribed. IFF has filed under the Securities Act a registration statement on Form S-4 (Registration No. 333-238072) to register the shares of IFF common stock into which shares of N&B common stock will be converted in the Merger.
This Amendment No. 3 shall be read together with the Schedule TO. Except as specifically provided herein, this Amendment No. 3 does not modify any of the information previously reported on the Schedule TO.
Item 11. Additional Information.
Item 11 of the Schedule TO is hereby amended and supplemented by adding the following text:
On January 26, 2021, DuPont issued a press release announcing preliminary fourth quarter and preliminary full year 2020 results for DuPont and its Nutrition & Biosciences segment. A copy of the release is attached as Exhibit (a)(5)(xxii) hereto and is incorporated herein by reference. The information incorporated by reference from Exhibit (a)(5)(xxii) shall be deemed filed solely for purposes of this Schedule TO and, as stated in DuPonts Current Report on Form 8-K filed January 26, 2021, for purposes of incorporation by reference into N&Bs registration statement on Form S-1/S-4 of (Registration Number 333-238089) and the prospectus, dated December 31, 2020, contained therein, and IFFs registration statement on Form S-4 (Registration Number 333-238072) and the prospectus, dated December 31, 2020, contained therein. Other than the foregoing, the information contained in Exhibit (a)(5)(xxii) attached hereto shall be considered furnished for all other purposes and shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of Section 18 and shall not be deemed to be incorporated by reference into any other registration statement or other document filed by DuPont pursuant to the Securities Act of 1933, as amended.
Item 12. Exhibits.
Item 12 of the Schedule TO is amended and supplemented by adding the following exhibits thereto:
Exhibit
|
Description |
|
(a)(5)(xxi) | Text of the website that is being maintained in connection with the Exchange Offer, updated on January 25, 2021, incorporated by reference to DuPonts Form 425 filed on January 26, 2021 | |
(a)(5)(xxii) | Press Release by DuPont, dated January 26, 2021, incorporated by reference to Exhibit 99.1 to DuPonts Form 8-K filed on January 26, 2021 |
SIGNATURE
After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
DUPONT DE NEMOURS, INC. | ||
By: |
/s/ Lori D. Koch |
|
Name: Lori D. Koch | ||
Title: Executive Vice President and Chief Financial Officer |
Dated: January 26, 2021
1 Year DuPont de Nemours Chart |
1 Month DuPont de Nemours Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions